Skip to main content

JDRF has now rebranded to Breakthrough T1D.
Our name has changed, our mission has not.

News

New report calls for more equal access to type 1 diabetes technology

Our Access For All report, launched today, highlights how far we’ve come with advancements in diabetes technology, but shows that many people still face barriers when trying to access T1D technology.
Breakthrough T1D profile picture
Breakthrough T1D staff 29 October 2024

A young woman wearing a continuous glucose monitor looks on to a man scanning his sensor.

In our new report, Access For All: The impact of technology on the lives of people with type 1 diabetes we’ve updated the market research we first conducted in 2019 for Pathway to Choice, to see how things have progressed. The good news is that more people are using diabetes tech, but there’s still a long way to go. There are big differences in access across the UK, and many people are still missing out on devices that could make a huge difference in their daily lives.

The market research, conducted in autumn 2023, explored how people with type 1 and their families use these technologies and their impact. By understanding how people feel about these technologies, we can improve care and support for everyone with T1D.

The use of tech in 2024

Technology for managing type 1 diabetes has come a long way in recent years, with devices becoming more wearable, user-friendly, and integrated with mobile phones. These advancements ease the daily challenges of managing T1D, from insulin injections to monitoring glucose levels, and help reduce the risk of complications. Pioneering technology, like hybrid closed-loop systems, now reduces the number of daily decisions people with T1D have to make, helping to improve quality of life.

While great progress is being made—especially with hybrid closed-loop technology now available on the NHS in England, Scotland, and Wales, and under consideration in Northern Ireland—there are still major challenges. Limited availability of devices on the NHS and healthcare professionals not always recommending these technologies are significant barriers that need to be addressed.

Our Chief Executive, Karen Addington, said:

“Technology can truly transform the lives of people with type 1 diabetes. Devices that help with precise insulin dosing and continuous glucose monitors can reduce the daily stresses of managing T1D. But we know not everyone has equal access to these life-changing tools, and that needs to change. Exciting breakthroughs in cellular therapies offer hope for future treatments that could even cure type 1 diabetes. But right now, we need to make sure that everyone has access to the best technology available. That’s why we’ve done this market research—so we can better understand people’s experiences with diabetes tech and work to improve access for everyone.”

Key findings

Most people know about insulin injections, pumps, and glucose monitors like CGM and flash monitors, but only 25% have heard of HCL. Many try T1D tech because healthcare professionals recommend it, or they’re encouraged by friends and family who’ve used it. Barriers include limited access on the NHS, complicated devices, and devices’ appearance. Those using the tech say it helps with blood glucose management and makes them feel happier and less anxious, especially with HCL. There’s also a lot of interest in future treatments like beta cell transplants, but many are hesitant to be among the first to try new treatments.

Recommendations

The report recommends increasing awareness of hybrid closed-loop (HCL) systems, ensuring those who could benefit are included in the rollout, and providing comprehensive training for healthcare professionals. It also calls for a national diabetes registry, an early detection programme for type 1 diabetes, and ongoing support for those testing positive for biological markers. Additionally, the report urges the approval of drugs delaying type 1 diabetes by NICE, better patient education on emerging therapies, and increased awareness of clinical trials for future treatments.

Moving forward together

We’re committed to ensuring that no one living with T1D is left behind. Using the findings of the report, we’re working with the NHS, Parliamentarians, other charities and industry stakeholders to address systemic issues across the UK to ensure fair and equitable access to existing and emerging treatments to everyone with T1D.

Read the full report Access For All: The impact of technology on the lives of people with type 1 diabetes

The survey report was conceived, developed and led by Breakthrough T1D under its Access for All programme which is sponsored by Abbott, Dexcom and Insulet.

Sanofi provided funding to Breakthrough T1D to support costs associated with this research and report but had no influence or editorial involvement in the project or its outputs.

You may also be interested in

Read more
An older woman using a mobile phone app to scan her glucose sensor as part of type 1 diabetes management

Our guide to type 1 technology

Learn more about insulin pumps, continuous glucose monitors, smart insulin pens and hybrid closed loop systems.

Read more
A man in a pink shirt and a black tie stands in front of the UK Houses of Parliament

Making treatments available

Find out about our work to make T1D treatments available to everyone who needs or wants them.

Read more
A photo of a researcher standing beside a microscope showing an image on a monitor beside it on a lab bench.

Our research

Find out about our research to find cures for T1D and make everyday life better for those who face it.

Related news

Read more
Mum and daughter wearing Breakthrough T1D t-shirts and holding a flag in a park.
News
16 December 2024

Research and policy breakthroughs in 2024

Our highlights from a year full of breakthroughs in type 1 diabetes research and advocacy.

Read more
A photograph of two women. The woman on the right is a healthcare professional who has a hand on the other woman's arm.
Research
12 November 2024

New policy framework launches to improve sex and gender data in UK research

The framework aims to encourage UK researchers to consider different sexes (biological attributes) and genders (roles, behaviours and identity in society) to address gaps in health data.

Read more
A researcher sits in a lab beside screening samples and lab equipment for early detection of type 1 diabetes.
Research
24 June 2024

New guidance sets out how to support people with early-stage type 1 diabetes

New international guidance detailing how to monitor and support people with early-stage type 1 diabetes (T1D) has the potential to reduce the trauma associated with being diagnosed with T1D, enable people to access the latest treatments to delay the need for insulin therapy, and reduce long-term health complications.

Read more
Would I Lie To You? Banner
Advocacy
1 February 2024

Our letter to the producers of Would I Lie to You?

We wrote to the producers of the hit BBC show after they broadcast jokes about type 1 diabetes.

Connect with us on social